Loading clinical trials...
Loading clinical trials...
Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multi- Centre, Adaptive Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For SARS-CoV-2 Infection
Conditions
Interventions
Ramatroban
Placebo
Locations
7
India
DEC Health Care
Nellore, Andhra Pradesh, India
Shakti Superspecialty Hospital
Ahmedabad, Gujarat, India
Lifecare Hospital
Mumbai, Maharashtra, India
Sangvi Multispecialty Hospital Pvt Ltd
Pune, Maharashtra, India
Saikrupa Hospital
Pune, Maharashtra, India
Spandan Hospital
Pune, Maharashtra, India
Start Date
November 10, 2022
Primary Completion Date
July 1, 2024
Completion Date
May 31, 2026
Last Updated
January 31, 2023
NCT06402318
NCT06927622
NCT05562505
NCT06490744
NCT05040659
NCT05019456
Lead Sponsor
KARE Biosciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions